非增强CT征象预测脑出血扩大与不良预后:荟萃分析
该荟萃分析纳入25项观察性研究或随机对照试验(n=10,650),评估非增强CT征象与自发性脑出血患者血肿扩大及功能预后的关联。结果显示,黑洞征、漩涡征、混合密度、岛征等密度和形态特征与血肿扩大及不良预后风险升高相关,效应量各异。
要点
- 多种非增强CT形态和密度征象与血肿扩大及不良预后独立相关。
- 岛征和黑洞征对血肿扩大和不良预后的OR值较高,效应量较大。
- 这些征象可为未来随机对照试验提供风险分层信息。
核心结论
- 多种非增强CT脑出血形态和密度特征与血肿扩大及临床预后相关,效应量不同,可能为未来随机对照试验提供有用信息。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed英文观察性研究或随机对照试验,纳入至少50例自发性脑出血患者,共25项研究(n=10,650)。
主要发现
- 黑洞征与血肿扩大OR=3.70(95%CI 1.42-9.64)、不良预后OR=5.26(95%CI 1.75-15.76)相关。
- 漩涡征与血肿扩大OR=3.33(95%CI 2.42-4.60)、不良预后OR=3.70(95%CI 2.47-5.55)相关。
- 混合密度与血肿扩大OR=2.74(95%CI 1.71-4.39)、不良预后OR=2.80(95%CI 1.78-4.39)相关。
- blend sign与血肿扩大OR=3.49(95%CI 2.20-5.55)、不良预后OR=2.21(95%CI 1.16-4.18)相关。
- 低密度影与血肿扩大OR=3.47(95%CI 2.18-5.50)、不良预后OR=2.94(95%CI 2.28-3.78)相关。
关键数值与推荐
- 血肿扩大定义包括>33%、>33%和/或>6 mL、>33%和/或>12.5 mL。
- 不良功能预后定义为出院或90天改良Rankin量表3-6或4-6分。
- 不规则形状与血肿扩大OR=2.01(95%CI 1.27-3.19)、不良预后OR=3.43(95%CI 2.33-5.03)相关。
- 岛征与血肿扩大OR=7.87(95%CI 2.17-28.47)、不良预后OR=6.05(95%CI 4.44-8.24)相关。
临床怎么用
- 临床可依据非增强CT征象(如黑洞征、岛征、漩涡征等)识别血肿扩大和不良预后高风险患者。
- 不同征象效应量不同,岛征和黑洞征的OR值较高,可能有助于风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide precise estimates of the association between noncontrast CT (NCCT) markers, hematoma expansion (HE), and functional outcome in patients presenting with intracerebral hemorrhage (ICH) through a systematic review and meta-analysis. METHODS: We searched PubMed for English-written observational studies or randomized controlled trials reporting data on NCCT markers of HE and outcome in spontaneous ICH including at least 50 subjects. The outcomes of interest were HE (hematoma growth >33%, >33% and/or >6 mL, >33% and/or >12.5 mL), poor functional outcome (modified Rankin Scale 3-6 or 4-6) at discharge or at 90 days, and mortality. We pooled data in random-effects models and extracted cumulative odds ratio (OR) for each NCCT marker. RESULTS: We included 25 eligible studies (n = 10,650). The following markers were associated with increased risk of HE and poor outcome, respectively: black hole sign (OR = 3.70, 95% confidence interval [CI] = 1.42-9.64 and OR = 5.26, 95% CI = 1.75-15.76), swirl sign (OR = 3.33, 95% CI = 2.42-4.60 and OR = 3.70; 95% CI = 2.47-5.55), heterogeneous density (OR = 2.74; 95% CI = 1.71-4.39 and OR = 2.80; 95% CI = 1.78-4.39), blend sign (OR = 3.49; 95% CI = 2.20-5.55 and OR = 2.21; 95% CI 1.16-4.18), hypodensities (OR = 3.47; 95% CI = 2.18-5.50 and OR = 2.94; 95% CI = 2.28-3.78), irregular shape (OR = 2.01, 95% CI = 1.27-3.19 and OR = 3.43; 95% CI = 2.33-5.03), and island sign (OR = 7.87, 95% CI = 2.17-28.47 and OR = 6.05, 95% CI = 4.44-8.24). CONCLUSION: Our results suggest that multiple NCCT ICH shape and density features, with different effect size, are important markers for HE and clinical outcome and may provide useful information for future randomized controlled trials.
引用
- Morotti A, Arba F, Boulouis G, et al. Noncontrast CT markers of intracerebral hemorrhage expansion and poor outcome: A meta-analysis. Neurology. 2020. PMID: 32847959. doi:10.1212/WNL.0000000000010660
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。